Nurse Practitioner, Family · Cleveland, OH
NPI
1023161098
Since 2007
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
11100 Euclid Ave
Cleveland, OH, 44106
Phone (216) 844-3591
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,519
40 services
Medicare patients, 2024
23
Average age 67
Drug cost, 2024
$3.8M
1,142 prescriptions
Company payments, 2025
$11K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sophia D Woodson was code 99215 (office e&m - established), 22 times for 15 patients. In total Sophia D Woodson billed 40 services in 4 codes, and Medicare paid $2,519.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 22 | 15 | $81.44 | $1,792 |
By year: 2022 $3,099 for 63 services; 2023 $1,680 for 31 services; 2024 $2,519 for 40 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sophia D Woodson prescribed most often to Medicare patients was Baclofen, with 155 prescriptions and refills. In total Sophia D Woodson wrote 1,142 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 155 | 329 | 45 | $3,453 |
| Gabapentin Generic | 122 | 180 | 25 | $1,898 |
| Dimethyl Fumarate Generic | 102 | 134 | 15 | $98K |
| Kesimpta Pen Ofatumumab | 94 | 94 | Under 11 | $823K |
| Vumerity Diroximel Fumarate | 63 | 69 | Under 11 | $596K |
| Dalfampridine Er Dalfampridine | 58 | 64 | Under 11 | $21K |
| Avonex Pen (4 Pack) Interferon Beta-1a | 57 | 57 | Under 11 | $462K |
| Tecfidera Dimethyl Fumarate | 53 | 53 | Under 11 | $497K |
| Amantadine Amantadine Hcl | 40 | 61 | Under 11 | $1,913 |
| Avonex (4 Pack) Interferon Beta-1a | 26 | 26 | Under 11 | $236K |
| Teriflunomide Generic | 25 | 25 | Under 11 | $36K |
| Tizanidine Hcl Generic | 25 | 49 | Under 11 | $311 |
| Amitriptyline Hcl Generic | 25 | 32 | Under 11 | $217 |
| Zeposia Ozanimod Hydrochloride | 22 | 22 | Under 11 | $195K |
| Fingolimod Fingolimod Hcl | 18 | 18 | Under 11 | $73K |
Brand drugs: - claims; generic drugs: 755 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sophia D Woodson $11K ($11K in general payments such as food, travel and fees) from 17 companies. The largest payer was Genzyme Corporation with $6,084.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 10 | $6,084 |
| Biogen, Inc. BIIB | 12 | $3,390 |
| Novartis Pharmaceuticals Corporation NVS | 17 | $402 |
| EMD Serono, Inc. MRK.DE | 6 | $321 |
| Genentech USA, Inc. ROG.SW | 11 | $220 |
| TG Therapeutics, Inc. TGTX | 2 | $191 |
| Amgen Inc. AMGN | 5 | $190 |
| Genentech, Inc. ROG.SW | 2 | $125 |
| Alexion Pharmaceuticals, Inc. AZN | 4 | $117 |
| Celgene Corporation BMY | 2 | $45.77 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.